Chemours Company is a global leader in chemistry and material science, specializing in the production of a diverse range of industrial solutions. The company focuses on developing innovative products in critical sectors such as advanced performance materials, fluoroproducts, and titanium technologies. Chemours plays a significant role in addressing environmental challenges, offering sustainable solutions that enhance performance while minimizing ecological impact. Their cutting-edge technologies cater to various industries, including electronics, automotive, construction, and manufacturing, aiming to drive progress and improve the quality of everyday life through their specialized chemical products. Read More
In the high-stakes world of hedge fund management, few strategies are as nerve-wracking—or potentially lucrative—as the contrarian "deep value" play. This month, the spotlight has fallen on Alta Fundamental Advisers, a New York-based firm led by Nicholas S. Danaher, which has disclosed a massive new position in The
The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, today announced the appointment of Michael Foley as President of Chemours Titanium Technologies (TT), effective February 2026. Foley succeeds Damián Gumpel, who is departing the company.
The cryptocurrency market is buzzing with the highly anticipated debut of several spot XRP Exchange-Traded Funds (ETFs), which have collectively surged towards an impressive $1 billion in assets under management (AUM) since their mid-November 2025 launch. This monumental inflow of capital, occurring within weeks of their introduction, marks a pivotal moment for the XRP ecosystem [...]
Chemours (CC) missed Q3 2025 earnings estimates, with EPS of $0.20 vs. $0.26 expected. Strong Opteon™ sales were offset by weak performance in other segments and a cautious Q4 outlook.
The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced its financial results for the third quarter 2025.
The Chemours Company (“Chemours”) (NYSE: CC) today announced that the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per share on the Company's common stock for the fourth quarter of 2025. The dividend will be paid on December 15, 2025, to stockholders of record as of the close of business on November 14, 2025.
The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) today announced that the Company expects to issue its third quarter 2025 financial results after market on Thursday, November 6, 2025.
NEW ORLEANS, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into The Chemours Company (NYSE: CC).
Corteva is exploring a breakup that would separate its seed and pesticide businesses. The move could reshape agriculture amid falling crop prices and rising costs.
The Chemours Company (“Chemours”) today announced that its Board of Directors has appointed Independent Director Mary Cranston as Chair of the Board and Alister Cowan to the role of Lead Independent Director, effective September 2, 2025. These appointments follow the departure of Dawn Farrell, who has accepted a position with the Canadian government as the Chief Executive Officer of the newly created Major Projects Office under the Building Canada Act.
DuPont agreed to sell its Aramids business, including Kevlar and Nomex brands, to Arclin for $1.8B. Deal aligns with DuPont's strategy to improve profitability and shareholders to benefit from Arclin's growth.
